Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for cosmetic and reconstructive plastic surgery. The company is headquartered in Alajuela, Costa Rica.
| Revenue (TTM) | $211.08M |
| Gross Profit (TTM) | $146.31M |
| EBITDA | $-29.45M |
| Operating Margin | -6.08% |
| Return on Equity | -133.30% |
| Return on Assets | -6.93% |
| Revenue/Share (TTM) | $7.13 |
| Book Value | $0.80 |
| Price-to-Book | 83.52 |
| Price-to-Sales (TTM) | 9.32 |
| EV/Revenue | 10.21 |
| EV/EBITDA | -26.29 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 45.20% |
| Shares Outstanding | $29.38M |
| Float | $19.22M |
| % Insiders | 10.15% |
| % Institutions | 102.22% |
Volatility is currently expanding